Loading...

Boston Scientific Corporation

BSX•NYSE
Healthcare
Medical - Devices
$62.07
$-3.62(-5.51%)
U.S. Market opens in 30h 27m

Boston Scientific Corporation (BSX) Stock Overview

Explore Boston Scientific Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap92.2B
P/E Ratio26.19
EPS (TTM)$2.39
ROE0.15%
Fundamental Analysis

AI Price Forecasts

1 Month$62.13
3 Months$66.03
1 Year Target$103.32

BSX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Boston Scientific Corporation (BSX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 43.29, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $103.32.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 26.19 and a market capitalization of 92.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-5.52%
5-Day Change
-3.14%
1-Month Change
-8.93%
3-Month Change
-32.91%
6-Month Change
-38.62%
Year-to-Date (YTD) Change
-34.91%
1-Year Change
-38.63%
3-Year Change
20.89%
5-Year Change
46.83%
All-Time (Max) Change
1349.69%

Contact Information

https://www.bostonscientific.com
508 683 4000
300 Boston Scientific Way, Marlborough, MA, 01752-1234

Company Facts

53,000 Employees
IPO DateMay 19, 1992
CountryUS
Actively Trading

Frequently Asked Questions